Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial - ScienceDirect
Tweets with replies by Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme - De Giorgi - 2019 - BJU International - Wiley Online Library
Sebastiano BUTI | Medical Doctor | MD, PhD | University Hospital of Parma, Parma | AOUP | Reparto di Oncologia medica - Page 8
thumbnail
Alessandro RIZZO | Medical Doctor | Ospedale Oncologico "Giovanni Paolo II" di Bari, Bari | IRCCS Bari | Department of Medical Oncology
Università di Bari, al via la «rivoluzione» dell'oncologia al Policlinico - La Gazzetta del Mezzogiorno
SCIENTIFIC REPORT 2010 - 2011 - IOV
Loop | Camillo Porta
Loop | Camillo Porta
Medical Oncology - ISPA
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey | PLOS ONE
Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid | 12OCTUBRE | Medical Oncology Department
Camillo Porta - insalutenews.it
Adult Urology | Journal of Urology
Camillo Porta - Medical Doctor - Università degli Studi di Bari | LinkedIn
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
Policlinico Bari, prof. Porta nuovo ordinario di Oncologia - La Gazzetta del Mezzogiorno
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology
Untitled
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology
Le nuove terapie contro il tumore al rene - YouTube
Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Prof. Camillo Porta – Epidemiologia del Carcinoma Renale a Cellule Chiare - YouTube
